Pattern of Recurrence of Completely Resected Lung Adenocarcinoma Varies According to EGFR Mutation Status

被引：0
作者：
Watanabe, K. [1 ]
Sakamaki, K. [2 ]
Ito, H. [3 ]
Yokose, T. [4 ]
Yamada, K. [5 ]
Nakayama, H. [3 ]
Masuda, M. [6 ]
机构：
[1] Yokohama Med Ctr, Gen Thorac Surg, Yokohama, Kanagawa, Japan
[2] Univ Tokyo, Biostat & Bioinformat, Tokyo, Japan
[3] Kanagawa Canc Ctr, Dept Thorac Surg, Yokohama, Kanagawa, Japan
[4] Kanagawa Canc Ctr, Pathol, Yokohama, Kanagawa, Japan
[5] Kanagawa Canc Ctr, Thorac Oncol, Yokohama, Kanagawa, Japan
[6] Yokohama City Univ, Yokohama, Kanagawa, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
EGFR; Surgery; recurrence dynamics;
D O I：
10.1016/j.jtho.2018.08.1918
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.16-11
引用
收藏
页码：S1007 / S1007
页数：1
相关论文
共 50 条
  • [31] PREDOMINANT HISTOLOGIC SUBTYPE BY IASLC/ATS/ERS CLASSIFICATION IS CORRELATED WITH PROGNOSIS AND EGFR MUTATION IN SURGICALLY RESECTED LUNG ADENOCARCINOMA
    Yanagawa, Naoki
    Shiono, Satoshi
    Abiko, Masami
    Ogata, Shin-Ya
    Sato, Toru
    Tamura, Gen
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S414 - S415
  • [32] Prediction of distant recurrence in resected stage I and II lung adenocarcinoma
    Aramini, Beatrice
    Casali, Christian
    Stefani, Alessandro
    Bettelli, Stefania
    Wagner, Susanne
    Sangale, Zaina
    Hughes, Elisha
    Lanchbury, Jerry S.
    Maiorana, Antonino
    Morandi, Uliano
    LUNG CANCER, 2016, 101 : 82 - 87
  • [33] Prognostic value of TP53 co-mutation status combined with EGFR mutation in patients with lung adenocarcinoma
    Wang, Feng
    Zhao, Ning
    Gao, Ge
    Deng, Hong-Bin
    Wang, Zhi-Hui
    Deng, Li-Li
    Yang, Yu
    Lu, Changlian
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (11) : 2851 - 2859
  • [34] The Prognostic Role of PORT and EGFR Mutation Status in Completely Resected Stage IIIA/N2 Non-Small Cell Lung Cancer Patients with Postoperative Chemotherapy
    Yang, Hui
    Wang, Kunlun
    Li, Shenglei
    Li, Yan
    Yuan, Ling
    PATHOLOGY & ONCOLOGY RESEARCH, 2021, 27
  • [35] Prognostic value of TP53 co-mutation status combined with EGFR mutation in patients with lung adenocarcinoma
    Feng Wang
    Ning Zhao
    Ge Gao
    Hong-Bin Deng
    Zhi-Hui Wang
    Li-Li Deng
    Yu Yang
    Changlian Lu
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 2851 - 2859
  • [36] Combination of epidermal growth factor receptor mutation and the presence of high-grade patterns is associated with recurrence in resected stage I lung adenocarcinoma
    Kondo, Yasuto
    Ichinose, Junji
    Ninomiya, Hironori
    Hashimoto, Kohei
    Matsuura, Yosuke
    Nakao, Masayuki
    Ishikawa, Yuichi
    Okumura, Sakae
    Satoh, Yukitoshi
    Mun, Mingyon
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2022, 35 (02)
  • [37] Assessment of EGFR mutation status in Tunisian patients with pulmonary adenocarcinoma
    Toumi, A. Arfaoui
    Blel, A.
    Aloui, R.
    Zaibi, H.
    Ksentinini, M.
    Boudaya, M. S.
    Znaidi, N.
    Zidi, Y.
    Aouina, H.
    Rommani, S. Rammeh
    CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2018, 66 (03) : 65 - 70
  • [38] SURVIVAL ANALYSIS OF 106 FEMALE PATIENTS WITH COMPLETELY RESECTED LUNG ADENOCARCINOMA IN SHAANXI PROVINCE
    Dai, Yun
    Cao, Yanfei
    Li, Wei
    Tian, Wei
    Dou, Yawei
    Luo, Xianghui
    Li, Shudong
    Wang, Hongtao
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S629 - S630
  • [39] Uncommon EGFR Mutations as a Worse Prognostic Factor for Surgically Resected Lung Adenocarcinoma
    Hayasaka, K.
    Shiono, S.
    Matsumura, Y.
    Suzuki, H.
    Yanagawa, N.
    Abe, J.
    Sagawa, M.
    Sakurada, A.
    Katahira, M.
    Takahashi, S.
    Endoh, M.
    Okada, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S1004 - S1004
  • [40] The Impact of EGFR Mutations on the Prognosis of Patients with Resected Stage I Lung Adenocarcinoma
    Kitamura, Jiro
    Tapias, Luis
    Mathisen, Douglas
    Lanuti, Michael
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S620 - S621
12345